Log In
Print this Print this

tecarfarin (formerly ATI-5923)

  Manage Alerts
Collapse Summary General Information
Company Armetheon Inc.
DescriptionLong-acting inhibitor of vitamin K epoxide reductase complex subunit 1 (VKORC1)
Molecular Target Vitamin K epoxide reductase complex subunit 1 (VKORC1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II/III
Standard IndicationBlood clots
Indication DetailsPrevent blood clots; Prevent blood clots in patients with atrial fibrillation (AF)
Regulatory Designation U.S. - Special Protocol Assessment (Prevent blood clots)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today